Treatment of imipramine-induced dyspigmentation with Q-switched alexandrite laser therapy.
Orringer
Jeffrey S
JS
Department of Dermatology, Medical School, University of Michigan, Ann Arbor, Michigan, USA. jorringe@umich.edu
Lowe
Lori
L
Cha
Kelly B
KB
D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced* / Q000601:surgery*; D007099:Imipramine / Q000009:adverse effects*; D053844:Lasers, Solid-State / Q000627:therapeutic use*
D000929:Antidepressive Agents, Tricyclic; D007099:Imipramine